process that involves oxidative loads, muscle atrophy (arising from calpain, caspase-3, the autophagy-lysosomal pathway [ALP] and ubiquitin-proteasome system [UPS] activation), structural damage and muscle fibre remodelling, have not been fully explored. [4] [5] [6] Therefore, a detailed understanding of the precise mechanisms underlying VIDD is critical for the development of potential strategies to reduce the prolonged use of MV and thus ICU mortality.
Sepsis is a major risk factor for ICU patients developing diaphragm dysfunction.
2,3,7 During the progress of sepsis, deleterious host response to infectious constituents, such as lipopolysaccharide (LPS), may induce an inflammatory cascade and cause ventilator-associated pneumonia (VAP), subsequently leading to multiple organ failure. 5, [8] [9] [10] Animal studies have demonstrated that infection is a principal cause of abnormal diaphragm activities. 8, 11 Sepsis-mediated diaphragmatic weakness and VIDD involve common molecular pathways, namely excessive oxidative loads and mitochondrial abnormalities within the injured diaphragm myofibrils, suggesting that sepsis may be an accessory contributor to VIDD. 5, 6, 8, 10 In an acute lung injury (ALI), reactive oxygen species (ROS) are the major oxidants in the diaphragm and can be produced in mitochondria, sarcoplasmic reticula, sarcolemma, transverse tubes and cytosol within 6 hours of MV. 12, 13 Furthermore, sepsis and MV-induced oxidative stress may deteriorate diaphragm contractility and are critical contributors to proteolytic pathway activation. [14] [15] [16] The primary proteases in the skeletal muscle consist of (1) UPS, (2) calcium-related proteases and (3) lysosomal enzymes. 10, 17 The up-regulation of muscle-specific ubiquitin E3 ligases F-box protein atrogin-1 and muscle RING-finger proteins-1 (MuRF-1) is crucial for the proteolysis of monomeric myofibrillar proteins in the diaphragms of animals and patients using MV. [16] [17] [18] Increased autophagosome formation also occurs in MV-augmented diaphragmatic weakness, as reflected in an elevation of autophagic biomarker microtubule-related protein light chain (LC) 3. [19] [20] [21] Mitochondria are a principal source of diaphragmatic ROS and act as a pivotal upstream regulator that induces the molecular pathways engendering diaphragm muscle atrophy during endotoxaemia or MV. 22, 23 In addition, myonuclear apoptosis can also be accelerated by mitochondrial ROS, elevated cellular calcium levels and sarcoplasmic reticulum stress-induced activation of calpain and caspase-3. 20, 24 Furthermore, sepsis and MV-induced oxidative stress may up-regulate the production of inflammatory mediators, including high-mobility group box 1 (HMGB1), interleukin 6 (IL- 6) and plasminogen activator inhibitor-1 (PAI-1), 9, 15, [25] [26] [27] [28] [29] and subsequently impair diaphragm activities.
Rodent studies of endotoxaemia have revealed that toll-like receptor 4 (TLR4) modulates diaphragm injury by activating the nuclear factor-κB (NF-κB) pathway. 11, 30 In our previous mouse study investigating sepsis, the reduced ALP and mitigated mitochondrial ultrastructural changes were observed by inhibiting TLR4/NF-κB signalling through genetic manipulation of TLR4 using homozygous knockout. 31 TLR4 is the most renowned receptor of the TLR family and is crucial for the recognition of the damage-associated molecular pattern (DAMP), including extracellular matrix components, HMGB1 and LPS. 30, 32 Although inhibition of TLR4 could be an effective therapeutic strategy for VIDD, in light of the potential risk of increased infectious complications using this approach, targeting endogenous TLR4 ligands such as HMGB1 could be more prudent. Related studies have demonstrated that the expression levels of HMGB1 are associated with diaphragmatic dysfunction in caecal ligation and puncture in animals and that the administration of anti-HMGB1 antibodies can effectively attenuate sepsis-induced diaphragm dysfunction in septic rats. 26, 28 Several related studies have demonstrated that ethyl pyruvate, a potent free radical scavenger, can inhibit HMGB1 production and improve the survival of critically ill patients. 33, 34 Nevertheless, the use of ethyl pyruvate for the management of VIDD is still unexplored.
Murine endotoxaemia models have been employed to recapitulate human sepsis for nearly a century. 35 In this study, we investigated that the impact of MV with or without LPS and related HMGB1 signalling contributes to VIDD using a murine model of endotoxaemia. We hypothesized that the administration of ethyl pyruvate or anti-HMGB1 antibody would diminish HMGB1 expression, diaphragmatic structural damage, generation of free radicals, proteolytic protein synthesis and mitochondrial dysfunction and restore muscle contractility in the diaphragm of mice with or without endotoxaemia exposed to MV. 
| MATERIAL S AND ME THODS

| Experimental animals
| Experimental groups
Animals were randomly distributed into six groups in each experiment: group 1, non-ventilated control wild-type mice with normal saline; group 2, non-ventilated control wild-type mice with LPS; group 3, tidal volume (V T ) 10 mL/kg wild-type mice with normal saline; group 4, V T 10 mL/kg wild-type mice with LPS; group 5, V T 10 mL/kg wild-type mice after ethyl pyruvate (100 mg/kg) administration with LPS; group 6, V T 10 mL/kg wild-type mice after anti-HMGB1 antibody (100 mg/kg) with LPS; group 7, V T 10 mL/kg wild-type mice after ethyl pyruvate (50 mg/kg) administration with LPS; group 8, V T 10 mL/kg wild-type mice after anti-HMGB1 antibody (50 mg/kg) administration with LPS; group 9, V T 10 mL/kg wildtype mice after anti-HMGB1 isotype control antibody (100 mg/kg) administration with LPS. In groups 1-6, three mice underwent transmission electron microscopy (TEM) and specific force, and five mice underwent measurement for immunohistochemistry assay, inflammatory cytokines, protein carbonyl groups, superoxide dismutase, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labelling (TUNEL) assay, and Western blots. In groups 7-9, five mice underwent measurement for HMGB1 and Western blots.
| Ventilator protocol
We used our established murine model of VILI, as described previously. 9, 31 Briefly, a 20-gauge angiocatheter was inserted into the tracheotomy orifice of mice and general anaesthesia was maintained by regular intraperitoneal administration of zoletil 50 (5 mg/kg) and xylazine (5 mg/kg) at the beginning of the experiment and every 30 minutes. The depth of anaesthesia was monitored from heart rates, respiratory rates and limb reflexes induced by paw and tail pinches performed periodically. The mice were placed in a supine position on a heating blanket and then attached to a Harvard apparatus ventilator, model 55-7058 (Harvard Apparatus, Holliston, MA), set as tidal volume of 10 mL/kg at a rate of 100 breaths per min, for 8 hours while breathing room air with zero end-expiratory pressure.
Schellekens et al and our previous work demonstrated that 8-hour MV in mice can induce increased cytokine expression, lysosomal autophagy and diaphragm atrophy. 9, 31 At the end of the study, heparinized blood was taken from the arterial line for analysis of arterial blood gas, and the mice were sacrificed. The non-ventilated control mice were anaesthetized and sacrificed immediately.
| LPS and pharmacological inhibitors
Mice were administrated intravenously with either 1 mg/kg of Salmonella typhosa LPS (Lot 81H4018; Sigma Chemical Co., St. Louis, MO) or an equivalent volume of normal saline via the internal jugular vein as a control. After 1 hour of spontaneous respiration to allow for developing a septic response, the mice were subjected to MV for 8 hours. 9, 31, 36 Two doses of ethyl pyruvate (Sigma, St Louis, MO) were administered intraperitoneally. The first dose was administered 30 minutes before the mice were subjected to MV and the second dose was used after the mice were subjected to 4 hours of MV. 29, 34 Anti-HMGB1
antibody 100 mg/kg (chicken anti-pig HMGB1 polyclonal antibody, SHINO-TEST, Tokyo, Japan) or isotype control antibody (non-immune immunoglobulin G, SHINO-TEST, Tokyo, Japan) was administered intravenously 30 minutes before the start of MV. 28 The doses of ethyl pyruvate and anti-HMGB1 were chosen on the basis of our and other studies that showed 100 mg/kg ethyl pyruvate or anti-HMGB1 had better effects on inhibiting HMGB1 activity. 28, 29, 34 2.5 | Detection of cytokines in the bronchoalveolar lavage fluid PAI-1, with a lower detection limit of 0.02 ng/mL, and HMGB1 (1 ng/ mL) were detected in bronchoalveolar lavage (BAL) fluid using immunoassay kits containing primary polyclonal anti-mouse antibodies that were cross-reactive with rat and mouse PAI-1 and HMGB1
(PAI-1: Molecular Innovations, Inc, Southfield, MI; HMGB1: ShinoTest corporation, Kanagawa, Japan). Each sample was run in duplicate, according to the manufacturer's instructions.
| Immunoblot analysis
The diaphragms were homogenized in 1 mL of lysis buffer (20 
| Immunohistochemistry
The diaphragms were paraffin embedded, sliced at 4 μm, deparaffinized, 
| Real-time polymerase chain reaction
For isolating total RNA, the lung tissues were homogenized in TRIzol reagents (Invitrogen Corporation, Carlsbad, CA), according to the manufacturer's instructions. Total RNA (1 μg) was reverse transcribed using a GeneAmp polymerase chain reaction (PCR) system 9600 (PerkinElmer, Life Sciences, Inc, Boston, MA), as previously described. 31 The following primers were used for real-time polymerase chain reaction:
HMGB1, forward primer 5′-TGGCAAAGGCTGACAAGGCTC-3′ and reverse primer 5′-GGATGCTCGCCTTTGATTTTGG-3′ and GAPDH as internal control, forward primer 5′-GGAGCGAGACCCCACTAACA-3′
and reverse primer 5′-ACATACTCAGCACCGGCCTC-3′ (Protech Technology Enterprise Co., Ltd., Taipei, Taiwan). 37, 38 All quantitative PCR reactions using SYBR Master Mix were performed on a CFX96
Touch Real-Time PCR Detection system (Bio-Rad Laboratories, Inc, Hercules, CA). All PCR reactions were performed in duplicate and heated to 95°C for 5 minutes followed by 40 cycles of denaturation at 95°C for 10 seconds, and annealing at 55°C for 30 seconds. The relative gene expression was calculated using 2 −ΔΔCT method and the standard curves (cycle threshold values vs template concentration) were prepared for each target gene and for the internal control (GAPDH) in each sample. The specific gene's cycle threshold (Ct) values were normalized to the GAPDH and compared with the nonventilated control group with LPS that was assigned a value of 1 to calculate the relative fold change in expression.
| Statistical evaluation
The Western blots were quantitated using a National Institutes of Health (NIH) image analyser Image J 1.27z (National Institutes of F I G U R E 1 Electron microscopy and muscle force-frequency activity of the diaphragm. Representative micrographs of the longitudinal sections of diaphragm (×20 000: upper panel; ×40 000: lower panel) were from the same diaphragms of non-ventilated control mice and mice ventilated at a tidal volume (V T ) of 10 mL/kg (V T 10) for 8 h with or without LPS administration (n = 3 per group). (A and B) Non-ventilated control wild-type mice with or without LPS treatment: normal sarcomeres with distinct A bands, I bands and Z bands; (C) 10 mL/kg wild-type mice without LPS treatment (normal saline): increase of diaphragmatic disarray; (D) 10 mL/kg wild-type mice with LPS treatment: disruption of sarcomeric structure with loss of mitochondrial swelling, streaming of Z bands and collection of lipid droplets; (E) 10 mL/kg wild-type mice pretreated with ethyl pyruvate: reduction of diaphragmatic disruption. (F) Diaphragm musclespecific force production was measured as described in Materials and Methods2. Mitochondrial swelling with concurrent loss of cristae and autophagosomes containing heterogeneous cargo are identified by arrows. Ethyl pyruvate, 100 mg/kg, was given intraperitoneally 30 min before mechanical ventilation and 4 h after mechanical ventilation. *P < 0.05 vs the non-ventilated control mice with LPS treatment; † P < 0.05 vs all other groups. Scale bar represents 500 nm. EP, ethyl pyruvate; Hz, hertz; LPS, lipopolysaccharide; N, Newton to assess the statistical significance of the differences, followed by multiple comparisons with a Scheffe′s test, and a P < 0.05 was considered statistically significant. We have performed the ShapiroWilk normality test and verify that all data are parametric (P > 0.05).
Additional details, including measurement of diaphragm force-frequency relationships, immunoblot analysis, immunohistochemistry, mitochondrial isolation, measurement of diaphragmatic oxidative stress and antioxidant enzyme expression, TEM and TUNEL assay were performed as previously described. 9, 31 3 | RE SULTS
| Reduction of the effects of MV on endotoxinenhanced VIDD, oxygen radicals and inflammatory cytokines using ethyl pyruvate
We employed MV (10 mL/kg) at room temperature for 8 hours to elicit VIDD in mice. The physiological conditions at the beginning and end of MV are listed in Table S1 . Normovolemic status was sustained in the mice by monitoring their mean arterial pressure. The dose-dependent responses of ethyl pyruvate and anti-HMGB1 used F I G U R E 2 Ethyl pyruvate abrogated endotoxin-augmented mechanical ventilation-induced oxidative stress, inflammatory cytokines, calpain, atrogin-1 and MuRF-1 expression in the diaphragm. (A) protein carbonyl groups (diaphragm), (B) SOD (diaphragm), (C) BAL fluid active PAI-1 and (D) BAL fluid HMGB1 were from the non-ventilated control mice and mice ventilated at a tidal volume of 10 mL/kg for 8 h with or without LPS administration (n = 5 per group). Western blots were performed using antibodies that recognize calpain (E), atrogin-1 (F), MuRF-1 (G) and GAPDH expression from the diaphragms of non-ventilated control mice and mice ventilated at a tidal volume of 10 mL/ kg for 8 h with or without LPS administration (n = 5 per group). Arbitrary units were expressed as relative calpain, atrogin-1 and MuRF-1 activation (n = 5 per group). Ethyl pyruvate, 100 mg/kg, was given intraperitoneally 30 min before mechanical ventilation and 4 h after mechanical ventilation. *P < 0.05 vs the non-ventilated control mice with LPS treatment; † P < 0.05 vs all other groups. BAL, bronchoalveolar lavage; GAPDH, glyceraldehydes-phosphate dehydrogenase; HMGB1, high-mobility group box-1; MuRF-1, muscle ring finger-1; PAI-1, plasminogen activator inhibitor-1; SOD, sodium dismutase in this study were described in supplementary data ( Figure S1 ). TEM was performed to explore MV-and LPS-induced changes in the dia- was observed in mice with endotoxaemia subjected to V T 10 mL/kg compared to those without endotoxaemia subjected to V T 10 mL/kg and the non-ventilated control mice. The elevated HMGB1 expression levels after MV were substantially diminished after the administration of either ethyl pyruvate or anti-HMGB1 antibody ( Figure 3B ).
| Reduction of the effects of MV on endotoxinaugmented VIDD by ethyl pyruvate and anti-HMGB1 antibody
To determine the role of HMGB1 activation in stretch-induced 
| Suppression of the effects of MV on endotoxin-enhanced expression of caspase-3 and diaphragm apoptosis by ethyl pyruvate and anti-HMGB1 antibody
Studies have demonstrated that caspase-3 is crucial to the intrinsic apoptotic pathway. 20, 31 Capase-3 expression and TUNEL staining were used to identify the roles of the caspase-3 pathway and apoptosis of diaphragm myofibrils in endotoxin-related VIDD ( Figure 6 ).
A substantial up-regulation in caspase-3 expression and the emergence of TUNEL-positive apoptotic nuclei in the murine diaphragm occurred in mice with endotoxaemia subjected to V T 10 mL/kg, but not in those without endotoxaemia subjected to V T 10 mL/kg and the non-ventilated control mice ( Figure 6B,C) . Specifically, the activation in caspase-3, as well as MV-and endotoxin-enhanced apoptosis, in the murine diaphragm was restored following the administration of ethyl pyruvate as well as anti-HMGB1 antibody.
Collectively, our results suggest that endotoxin-and concurrent MV-mediated oxidative loads and the inflammatory reactions in the diaphragm were protected by the inhibition of the HMGB1 pathway ( Figure 7 ).
| D ISCUSS I ON
In clinical practice, MV is required to provide adequate ventilation and oxygenation in patients with sepsis and respiratory insufficiency. Infection can trigger substantial diaphragm dysfunction in animal and clinical human studies of sepsis. 7, 15, 26 However, the use of MV can lead to the rapid development of diaphragm weakness and ventilator-induced lung injury (VILI) in humans. 3, 4 Recently, MV was determined to likely aggravate diaphragm injuries in a murine model of endotoxaemia. 31 The combination of infection and ventilator-induced diaphragm disuse exacerbated the diaphragmatic force-generating contractility in mechanically ventilated patients. protein-2 and tumour necrosis factor-α. 41, 42 Elevated HMGB1 levels have been observed in the pulmonary epithelial lining fluid of septic patients. 43 Moreover, HMGB1 was revealed to accelerate muscle fatigue, and is believed to be an early trigger of skeletal muscle dysfunction through binding to TLR4. HMGB1 is also believed to impair sarcoplasmic reticulum Ca 2+ release in patients with myositis. 30 High HMGB1 concentrations were observed to be associated with patients who required long-term MV use and those with VAP. 44 Previous studies on VILI have determined that MV can up-regulate the production of HMGB1 and that HMGB1 is a pivotal mediator in the development of VILI. 29, 45 Furthermore, a moderate V T of MV can aggravate LPS-induced lung injury by up-regulating HMGB1. 46 However, no studies have investigated the role of were from the non-ventilated control mice and mice ventilated at a tidal volume of 10 mL/kg for 8 h with or without LPS administration (n = 5 per group). Western blots were performed using antibodies that recognize calpain (E), atrogin-1 (F), MuRF-1 (G) and GAPDH expression from the diaphragms of non-ventilated control mice and mice ventilated at a tidal volume of 10 mL/kg for 8 h with or without LPS administration (n = 5 per group). Arbitrary units were expressed as relative calpain, atrogin-1 and MuRF-1 activation (n = 5 per group). Anti-HMGB1 antibody, 100 mg/kg, was administered intravenously 30 min before the start of ventilation. *P < 0.05 vs the non-ventilated control mice with LPS treatment; † P < 0.05 vs all other groups autophagy. These deleterious effects were attenuated by using the anti-HMGB1 antibody. Although ROS and early cytokines are important to contribute to VIDD, and herein, we provide the evidence that using anti-HMGB1 antibody can elevate the SOD activity and suppress the oxidants, inflammatory cytokines and VIDD comparable to the beneficial effects of ethyl pyruvate in this model (Figures   3-6 ). In addition, we proved that MV induces diaphragmatic injury in a mouse model of endotoxaemia through activation of the TLR4/ NF-κB signalling pathway. 31 This inspired us to investigate the role of HMGB1, a pivotal ligand of the TLR4 receptor, and develop an effective agent to improve VIDD during endotoxaemia.
Ethyl pyruvate, a simple aliphatic ester, is derived from the endogenous metabolite of pyruvic acid. Ethyl pyruvate can function as both a potent ROS scavenger and anti-inflammatory agent through the up-regulation of haem oxygenase-1 or suppression of the NF-κB and p38 mitogen-activated protein kinase (MAPK)-mediated inflammatory responses. [47] [48] [49] Ethyl pyruvate can also act as an HMGB1 inhibitor and ameliorate the systemic inflammation and organ dysfunction in animal models of endotoxaemia and sepsis. 33, 50 In addition, a proprietary formulation of ethyl pyruvate was proven to be safe and well tolerated at clinically relevant dosages in clinical trials on healthy subjects and patients who underwent cardiac surgery. 47 However, the application of ethyl pyruvate for diaphragmatic injury induced by the combination of MV and LPS has not been investigated. To the best of our knowledge, this is the first study to examine the salutary effects of ethyl pyruvate on diaphragmatic dysfunction associated with inflammation, proteolysis, apoptosis, autophagy and mitochondrial injury. A considerable amount of research has documented that oxidative stress mediates the release of the redox-sensitive protein HMGB1 during sepsis and can trigger mitochondrial permeability transition, inducing apoptosis, autophagy and mitochondrial damage by integrating the HMGB1. 51 Ethyl pyruvate is protective in the setting of experimental sepsis partly by inhibiting HMGB1 release and accumulation. 52 Mechanistically, ethyl pyruvate was determined to promote the deacetylation of HMGB1 through the signal transducer and activator of transcription 1 (STAT1) phosphorylation up-regulating sirtuin1, thereby reducing the release of HMGB1 in LPS-activated murine macrophages. 53 Li et al also documented that ethyl pyruvate preserved the mitochondrial integrity by inhibiting the nucleotide-binding domain, the leucine-rich-containing family and the pyrin domain-containing-3 (NLRP3) agonist-induced mitochondrial damage by acting as an NLRP3 inflammasome inhibitor in human acute monocytic leukaemia cell lines. 54 In the present study, we decreased NF-κB and plasma cytokines in 3 h, but those inflammatory parameters were elevated in 9 hours in high-dose LPS (30 mg/ kg)-challenged mice for survival test. 55 In the subsequent study, ethyl pyruvate at different doses of 100 mg/kg or 50 mg/kg was proven to reduce the mortality from endotoxin-induced ALI and the permeability index in mice. 34 Notably, the beneficial effects of 100 mg/kg ethyl pyruvate were superior compared to those of 50 mg/kg, which are consistent with our dose-response results ( Figure S1 ). A single intraperitoneal dose of ethyl pyruvate was able to reduce methaemoglobinaemia induced by dapsone for a short period of time of 3-6 h. 56 Thus, a second dose was designed to be given after the mice subjected to 4 hours of MV at our protocol. As for the toxicity of ethyl pyruvate, dosage up to 150 mg/kg was proven to be a safe and effective medication in endotoxaemic horses, and ethyl pyruvate (90 mg/kg) at 6-hour intervals for five more doses was used with safety in human trials. 57, 58 In addition, anti-HMGB1 antibody (100 mg/kg) can significant attenuate diaphragm dysfunction in septic rats, and the beneficial effect was comparable to the highest dose of 250 mg/kg, but was superior compared to the dose of 25 mg/kg, which are in accordance with our results ( Figure S1 ). 28 The present study had some limitations. First, in activated neutrophils, HMGB1 induced p38 MAPK, extracellular signal-regulated kinases 1/2 and serine/threonine kinase/protein kinase B. It also increased the production of NF-κB-dependent inflammatory cytokines, including tumour necrosis factor-α, IL-6 and macrophage inflammatory protein-2, in lung tissue during infection and injury. 37, 42 Evidence has indicated that acetylation of HMGB1 prevents its entry into the nucleus and causes the release of HMGB1 from cells, thus initiating inflammation, as well as LPS-activated acetylation of HMGB1, through Janus Kinase/STAT signalling in TLR4-activated macrophages. 27, 59 Further investigation is necessary to explore other possible molecular mechanisms that involve HMGB1 and the advantageous effects of ethyl pyruvate in preventing patients with endotoxaemia from developing VIDD. Second, we utilized the anti-HMGB1 antibody in the study since HMGB1-/-mice die shortly after birth due to a defect in the transcriptional activation of the glucocorticoid receptor. 29 However, Kim et al reported that intranasal delivery of HMGB1 siRNA provides the neuroprotection in the ischaemic brain mediated by target gene knockdown. 60 Further alternative agents are expected to be researched in future studies.
By using an in vivo murine model of VIDD with endotoxaemia, we demonstrated that MV worsened LPS-challenged diaphragm F I G U R E 6 Ethyl pyruvate and anti-HMGB1 antibody ameliorated endotoxin-enhanced mechanical ventilation-mediated caspase-3 expression and apoptosis in the diaphragm. (A) Western blots were conducted using antibodies that recognize caspase-3 and GAPDH expression from the diaphragms of non-ventilated control mice and mice ventilated at a tidal volume of 10 mL/kg for 8 h with or without LPS administration (n = 5 per group). Arbitrary units were expressed as the ratio of cleaved caspase-3 to GAPDH (n = 5 per group). (B and C) Representative micrographs (×400) with TUNEL staining of paraffin diaphragm sections and quantification were from the diaphragms of non-ventilated control mice and mice ventilated at a tidal volume 10 mL/kg for 8 h with or without LPS administration (n = 5 per group). Ethyl pyruvate, 100 mg/kg, was given intraperitoneally 30 min before mechanical ventilation and 4 h after mechanical ventilation. Anti-HMGB1 antibody, 100 mg/kg, was administered intravenously 30 min before the start of ventilation. 
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